These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 29759721)

  • 41. Implantable cardioverter-defibrillator use in elderly patients receiving cardiac resynchronization: A meta-analysis.
    AlTurki A; Proietti R; Alturki H; Essebag V; Huynh T
    Hellenic J Cardiol; 2019; 60(5):276-281. PubMed ID: 29292244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure).
    Flett A; Cebula A; Nicholas Z; Adam R; Ewings S; Prasad S; Cleland JG; Eminton Z; Curzen N
    Am Heart J; 2023 Dec; 266():149-158. PubMed ID: 37777041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Luni FK; Singh H; Khan AR; Malik SA; Khawaja O; Riaz H; Lee W; Kabour A; Richards M; Aasbo J
    J Cardiovasc Electrophysiol; 2017 May; 28(5):538-543. PubMed ID: 28370885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRT-Pacemaker Versus CRT-Defibrillator Who Needs Sudden Cardiac Death Protection?
    Galand V; Martins RP; Behar N; Pichard C; Mabo P; Leclercq C
    Curr Heart Fail Rep; 2020 Aug; 17(4):116-124. PubMed ID: 32506301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.
    Sun WP; Li CL; Guo JC; Zhang LX; Liu R; Zhang HB; Zhang L
    Heart Fail Rev; 2016 Jul; 21(4):447-53. PubMed ID: 27043219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy.
    Liu F; Gao X; Luo J
    Front Cardiovasc Med; 2023; 10():1078570. PubMed ID: 37502189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).
    Buber J; Goldenberg I; Moss AJ; Wang PJ; McNitt S; Hall WJ; Eldar M; Barsheshet A; Shechter M
    J Am Coll Cardiol; 2012 Aug; 60(8):749-55. PubMed ID: 22703927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes.
    Hyman MC; Bao H; Curtis JP; Minges K; Schaller RD; Birgersdotter-Green U; Marchlinski FE; Hsu JC
    Heart Rhythm; 2020 Nov; 17(11):1878-1886. PubMed ID: 32497762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can we rely on Danish? Real-world data on patients with nonischemic cardiomyopathy from the German Device Registry.
    Frommeyer G; Andresen D; Ince H; Maier S; Stellbrink C; Kleemann T; Seidl K; Hoffmann E; Zrenner B; Hochadel M; Senges J; Eckardt L
    Heart Vessels; 2019 Jul; 34(7):1196-1202. PubMed ID: 30607538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex-specific clinical outcomes after cardiac resynchronization therapy in left bundle branch block-associated idiopathic nonischemic cardiomyopathy: A NEOLITH II substudy.
    Wang NC; Mezu-Chukwu U; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Shalaby AA; Voigt AH; Saba S
    Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12641. PubMed ID: 30919524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.
    Biton Y; Baman JR; Polonsky B
    Heart Fail Rev; 2016 Jul; 21(4):433-46. PubMed ID: 26910804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.
    McAlister FA; Ezekowitz J; Dryden DM; Hooton N; Vandermeer B; Friesen C; Spooner C; Rowe BH
    Evid Rep Technol Assess (Full Rep); 2007 Jun; (152):1-199. PubMed ID: 17764218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
    Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
    Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study.
    Wang NC; Li JZ; Adelstein EC; Althouse AD; Sharbaugh MS; Jain SK; Mendenhall GS; Shalaby AA; Voigt AH; Saba S
    Pacing Clin Electrophysiol; 2018 Feb; 41(2):143-154. PubMed ID: 29314085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mortality for the implantable cardiac defibrillator in nonischemic cardiomyopathy: An updated systematic review and meta-analysis.
    He W; Xue C; Zheng J; Shuai Z
    Clin Cardiol; 2022 Dec; 45(12):1163-1170. PubMed ID: 36056632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.